Clinical News

FDA clears first opioid withdrawal deviceFDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
How hospitals can cope with IV drug shortagesBecause of the impact of Hurricanes Maria and Irma on Puerto Rico’s infrastructure and drug manufacturing, hospitals face an ongoing shortage of IV fluids manufactured there.
FDA approves first pill that can be tracked when ingestedFDA approved the first drug in the United States that has a digital ingestion tracking system, which records when the medication was taken.
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
FDA issues warning over marijuana products claiming cancer cure
FDA issues warning over marijuana products claiming cancer cureFDA warned 4 companies, which are claiming that their products containing cannabidiol, can treat or cure cancer.
Game-changing hep B vaccine gets FDA nodThe first 2-dose hepatitis B vaccine, which was recently approved by FDA, is expected to be commercially available in early 2018.
FDA advisors recommend 2 opioid use disorder drugsTwo opioid use disorder drugs have been recommended for approval by FDA committees.
Activists: drugmakers, distributors liable for opioids abuseSoon after President Donald Trump announced declared the opioid abuse crisis a “public health emergency," shareholder activist groups said they aim to hold drug manufacturers and distributors liable for their part in the crisis.
New diabetes drug set to rival TrulicityIf it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly’s dulaglutide (Trulicity).
ISMP issues insulin pen warning after patient deathMore education is needed for diabetic patients after a patient died from incorrectly using an insulin pen, according to a new warning from the Institute for Safe Medication Practices.